SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.88-1.2%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mudcat who wrote (26743)12/5/1998 10:10:00 PM
From: LLCF  Read Replies (1) of 32384
 
<The Times reported that the FDA has been extremely lenient in approving drugs lately.>
<What would the delays be like if the FDA was actually following their own procedures (by the book)in approving Lgnd products.>

The fact is that the FDA is changing (albeit slowly), their whole way of looking at the process. What you're talking about IS by the book now... they're NOT going back.

<Many of the approvers in a survey said that they have been approving drugs that really should not have been approved.>

Any what exactly does this mean... does the NY Times talk about that? Looks to me that they are quoting the (liberal) Citizens Action Committee on a lot of this stuff. Does it mean the drugs are dangerous? That the drugs arent very effective? That they don't work at all?

Do you realize that in Japan all you have to really do is prove the drug won't hurt anyone [Phase 1 here]? That article may have been very misleading. If anything they'll get some more people on their staff and quite dragging their feet like all these government agencys do... you know they throw that stuff in a pile and say "great, we have 6 months on that one from today. Let me put it on my calander for April! Now, off to dunkin doghnuts."

DAK
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News